Pembrolizumab versus paclitaxel for previously treated patients with PD-L1-positive advanced gastric or gastroesophageal junction cancer (GC): Update from the phase III KEYNOTE-061 trial.
JOURNAL OF CLINICAL ONCOLOGY, vol.38, no.15, 2020 (Journal Indexed in SCI)
Article / Abstract
Title of Journal :
JOURNAL OF CLINICAL ONCOLOGY